Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
VNDA
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
vanda
trading
after
pharmaceuticals
market
wednesday
gained
estimates
rose
stocks
study
gets
fourth
announced
revenues
treatment
revenue
session
here
52w high -37.2%
VNDA
Vanda Pharmaceuticals Inc.
Stonvex
StonvexStonvexStonvexStonvex